BPC-157 is a synthetic pentadecapeptide supplied as a lyophilised powder in a sealed single-use vial for laboratory and analytical research purposes only. Each vial contains 10mg. Stock is held and dispatched from Australia with tracking, typically within 1-2 business days of order.
Specifications - Compound: BPC-157. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Format: lyophilised powder. Quantity: 10mg per vial. Purity: 98% minimum, analytically verified. Appearance: white to off-white lyophilised powder. Molecular weight: approximately 1419.5 g/mol. CAS number: 137525-51-0. Storage: 2-8 degrees C, sealed and protected from light. Intended use: laboratory research only.
Research context - BPC-157 is a 15-amino-acid synthetic peptide studied in preclinical and laboratory settings. Research commonly examines its stability under different experimental conditions, behaviour in cell and tissue models, and interaction with growth-factor-associated signalling pathways. Its relatively short sequence also makes it useful in peptide-characterisation, degradation and comparative stability studies. Findings from laboratory models do not establish safety or efficacy for human use. Genesis Peptides supplies BPC-157 in lyophilised form to support compound stability during transport and storage.
Handling and storage - Store the sealed vial refrigerated at 2-8 degrees C and protect it from heat and light. Use aseptic laboratory technique and reconstitute only according to an established research protocol using an appropriate research-grade diluent. Reconstituted material has a materially shorter stable life than lyophilised powder. Keep reconstituted material refrigerated and avoid repeated freeze-thaw cycles.
Compliance notice - This product is supplied strictly for laboratory research use only. Not for human consumption, veterinary use or therapeutic application. Not listed with the TGA. Genesis Peptides does not provide medical, therapeutic or clinical guidance.